SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
NCT05583409
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Stage IV Non-small Cell Lung Cancer
Interventions
RADIATION:
SBRT+Osimertinib
DRUG:
Osimertinib 80 MG
Sponsor
Li Zhang
Collaborators
[object Object]